Effect of endomentrial rceptivity on in vitro fertilization/intracytoplasmic sperm injection outcome in HUSM by Mohamadzon, Erinna
EFFECT OF ENDOMETRIAL RCEPTIVITY ON IN 
VITRO FERTILIZATION/ INTRACYTOPLASMIC 
SPERM INJECTION OUTCOME IN HUSM 
 
 
 
DR ERINNA BINTI MOHAMADZON 
 
 
DISSERTATION SUBMITTED  
IN PARTIAL FULFILLMENT OF THE REQUIREMENT FOR  
THE DEGREE OF MASTER OF MEDICINE  
(OBSTETRICS AND GYNECOLOGY) 
 
 
SCHOOL OF MEDICAL SCIENCES 
UNIVERSITI SAINS MALAYSIA 
2018 
i 
 
1.0   PRELIMINARIES 
1.1 TABLE OF CONTENTS 
  
1.0 PRELIMINARIES ............................................................................................ i 
1.1 TABLE OF CONTENTS ................................................................................. i 
1.2 ACKNOWLEDGEMENT ................................................................................ v 
1.3 ABSTRAK .................................................................................................... vii 
1.4 ABSTRACT ...................................................................................................ix 
2.0  INTRODUCTION .......................................................................................... 1 
2.1 Literature Review .......................................................................................... 1 
2.1.1 Endometrial thickness as an indicator for good endometrial receptivity .. 1 
2.2  Source population and sampling frame ......................................................... 3 
2.2.1 Endometrial morphology as indicator for good endometrial receptivity ... 3 
2.2.2 Effect of serum progesterone on endometrial receptivity ........................ 3 
2.3 Study Justification ......................................................................................... 4 
3.0  OBJECTIVES ............................................................................................... 6 
GENERAL OBJECTIVE .......................................................................................... 6 
SPECIFIC OBJECTIVES ........................................................................................ 6 
ii 
 
4.0  METHODOLOGY ......................................................................................... 7 
4.1 Study design, setting and duration ................................................................ 7 
4.2 Reference population .................................................................................... 7 
4.4  Sample size calculation ................................................................................. 7 
4.5  Ethics and consent ........................................................................................ 8 
4.6 Inform consent ............................................................................................... 9 
4.7 Inclusion and exclusion criteria ...................................................................... 9 
4.7.1 Inclusion criteria ...................................................................................... 9 
4.7.2 Exclusion criteria ..................................................................................... 9 
4.8 Sampling method and subject recruitment .................................................. 10 
4.9 Study method .............................................................................................. 10 
4.9.1 Stimulation protocol .............................................................................. 10 
4.9.2 Oocyte retrieval ..................................................................................... 11 
4.9.3 Embryo culture ...................................................................................... 12 
4.9.4 Embryo transfer .................................................................................... 12 
4.9.5 Determination of pregnancy .................................................................. 13 
4.10 Statistical analysis .................................................................................... 13 
4.11 Definition of operational term ................................................................... 14 
4.12 Study flow chart ....................................................................................... 15 
iii 
 
5.0  THE MANUSCRIPT ................................................................................... 16 
ABSTRACT ....................................................................................................... 18 
INTRODUCTION ............................................................................................... 20 
METHODOLOGY .............................................................................................. 21 
RESULTS .......................................................................................................... 23 
DISCUSSION .................................................................................................... 25 
Endometrial Receptivity ................................................................................. 26 
Endometrial thickness .................................................................................... 26 
Endometrial morphology ................................................................................ 28 
HCG day progesterone level .......................................................................... 29 
CONCLUSION ................................................................................................... 30 
REFERENCES .................................................................................................. 31 
TABLES AND FIGURES ................................................................................... 37 
6.0  APPENDICES ............................................................................................ 41 
6.1 RESULTS ................................................................................................ 42 
6.1.1 Outcome of IVF/ ICSI cycles ................................................................. 43 
6.1.2 Patients’ characteristic .......................................................................... 43 
6.1.3 Cycle characteristic ............................................................................... 45 
6.1.4 The association between endometrial thickness and outcome of IVF/ 
ICSI 47 
iv 
 
6.1.5 Endometrial morphology ....................................................................... 48 
6.2 LIST OF ABBREVIATION ........................................................................ 50 
6.3 SELECTED JOURNAL ............................................................................ 53 
6.3 ETHICAL COMMITTEE APPROVAL ....................................................... 53 
 
  
v 
 
1.2 ACKNOWLEDGEMENT 
“ In the name of Allah, Most Gracious, Most Merciful” 
Praises to Allah S.W.T, the lord of Al-Mighty for His blessing and generosity that gave me 
the strength and courage throughout the entire completion of this dissertation. I am very 
grateful that this dissertation has been completed with the contribution of many people. 
I would like to convey my deepest gratitude and great appreciation to my supervisor, 
Assoc. Prof Dr. Adibah Ibrahim, Senior Consultant Obstetrics and Gynaecologist, 
Department of Obstetrics and Gynaecology, Universiti Sains Malaysia for the kind 
assistance, encouragement and guidance to make this dissertation possible. 
Many thanks to Assoc. Prof Dr Mohd Pazudin Ismail, Head of Department Obstetrics and 
Gynaecologist, Department of Obstetrics & Gynaecology, Universiti Sains Malaysia and 
all lecturers who had contributed a lot during my master training. 
Most importantly, I am particularly indebted to my beloved husband, Dr Mohd Nazrul 
Hisham Yusoff for his support, understanding, encouragements, patience and endless 
pray.To my beloved parents, Hj Mohamad Zon Zakaria and Hajjah Rusnawati Juda, Mr 
Yusoff Mat and Ms Wan Khadijah Wan Nawang, thank you for bringing me up and 
support me, and to make me the way I am now. To the most wonderful presents I ever had, 
Mukhless, Mufeed and Ahmad Mursyeed, thank you for your patience and infinity loves. 
Not to forget, Bibik Rasni Jalal, thank you for your support and endless pray 
vi 
 
Last but not least, I like to forward my gratitude to my colleagues and all staff whose help 
made the completion of this study possible.  
Erinna Mohamad Zon 
   
vii 
 
1.3 ABSTRAK 
OBJEKTIF: Untuk menentukan kaitan di antara kesediaan endometrium dari segi 
ketebalan endometrium, rupa bentuk endometrium dan tahap progesteron darah dengan 
kebolehan mengandung pesakit-pesakit yang menjalani kitaran in vitro fertilization/ 
intracytoplasmic sperm injection (IVF/ ICSI). 
KAEDAH KAJIAN: Seramai 50 orang pesakit yang menjalani kitaran IVF/ ICSI di Unit 
Rawatan Masalah Kesuburan Hospital USM telah menyertai kajian yang dijalankan selama 
18 bulan ini. Pesakit-pesakit telah menjalani stimulasi ovari terkawal sehingga folikal 
bersaiz matang. Proses pengambilan benih wanita (oocyte retrieval) dilakukan dan 
seterusnya  benih-benih ini telah disenyawakan secara IVF/ ICSI. Pemindahan janin 
dilakukan semasa peringkat blastocyst. Kejayaan mengandung ditentukan dengan melihat 
tahap beta hCG di dalam darah yang diambil 14 hari selepas pemindahan janin. Analisa 
untuk melihat kaitan di antara ketebalan endometrium, rupa bentuk endometrium dan tahap 
progesteron semasa hari suntikan hCG dengan kebolehan mengandung telah dilakukan. 
KEPUTUSAN: 10 daripada 50 orang pesakit (20.0%) telah didapati positif mengandung. 
Purata ketebalan endometrium di kalangan mereka yang mengandung adalah 9.86 ±1.68 
mm, manakala purata ketebalan endometrium bagi kumpulan tidak mengandung adalah 
9.77+ 2.53 mm. 7 daripada 10 orang pesakit yang mengandung mempunyai rupa bentuk 
endometrium trilaminar. Purata tahap progesteron semasa hari suntikan hCG adalah 3.717 
± 1.071 nmol/L bagi kumpulan yang mengandung dan 1.408 ± 4.691 nmol/L bagi 
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kumpulan yang tidak mengandung. Kesemua perbezaan ini didapati tidak signifikan dari 
segi statistik.  
KESIMPULAN:   Tiada kaitan didapati di antara ketebalan endometrium, rupa bentuk 
endometrium dan tahap progesteron darah semasa hari suntikan hCG dengan hasil kitaran 
IVF/ ICSI. Walau bagaimanapun, keputusan ini tidak muktamad disebabkan oleh saiz 
sampel yang kecil.   
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1.4 ABSTRACT 
OBJECTIVE: To evaluate the association of endometrial receptivity by means of 
endometrial thickness, endometrial morphology and the level of serum progesterone with 
the outcome of in vitro fertilization/ intracytoplasmic sperm injection (IVF/ ICSI) cycles.    
STUDY METHOD: This prospective study was performed over a period of 18 months in 
Hospital USM Fertility Unit. A total of 50 patients going to receive IVF/ICSI cycles 
participated in the study. 50 subjects had undergone controlled ovarian hyperstimulation 
protocol until mature follicles were observed. On the day when the patient is to receive 
hCG injection, the endometrial thickness, endometrial morphology and the level of serum 
progesterone were determined. Oocyte retrieval was done which was followed by IVF or 
ICSI. The developed embryos were transferred into the uterus at blastocyst stage. Serum 
beta hCG was measured 14 days after embryo transfer. The association between 
endometrial thickness, endometrial morphology and level of serum progesterone with 
pregnancy was analyzed.  
RESULT: Pregnancy was achieved in 10 out of 50 patients (20.0%). The mean 
endometrial thickness for the pregnant group was 9.86 ±1.68 mm, whilst  9.77+ 2.53 mm in 
the non-pregnant group. 7 out of 10 pregnant patients had trilaminar endometrium. The 
mean progesterone level during the hCG day was 3.717 ± 1.071 nmol/L for the pregnant 
group and 1.408 ± 4.691 nmol/L for the non-pregnant group. All differences were not 
statistically significant. 
x 
 
CONCLUSION: Endometrial thickness, endometrial morphology and the level of serum 
progesterone on the hCG day was not significantly associated with the outcome of IVF/ 
ICSI cycles. However, this finding was guarded by the small sample size. 
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2.0  INTRODUCTION 
2.1 Literature Review 
Successful implantation requires good harmony between the endometrium with the 
embryo. Uterine receptivity accounts for about 31-64% of implantation. A blastocyst can 
implant into the endometrium only during short period of time called window of 
implantation. It is believed that it lasts about 48 hours, beginning 6-10 days after the LH 
surge in a spontaneous cycle. The window is advanced in clomiphene citrate or 
gonadotropin stimulated cycles and can delay in steroid hormone replacement cycles for 
donor recipients. There are many methods can be used to determine good endometrial 
receptivity, such as hormones manipulation, glycodelin, IGFBP-I, intergrin, myometrium, 
morphology and endometrial thickness (ET), and of recent is the progesterone level right 
after the LH surge.  
2.1.1 Endometrial thickness as an indicator for good endometrial 
receptivity 
Transvaginal ultrasound has been widely used to measure the endometrial thickness (ET) 
and this has been accepted as indicator for endometrial receptivity. It is cost effective and 
easily done by operator and widely available in all infertility unit.  
Although endometrial thickness is a predictor to the degree of endometrial maturation, 
there is no ET value that confirms pregnancy in IVF/ ICSI cycle.  Glissant et al in 1985 
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concluded that there was a significantly greater thickness in pregnant cycles, but did not 
indicate the cut off value which could enhance implantation (1).   
A retrospective study on ICSI by Bozdag et al in 2009 have shown that ET of less than 
7mm on the day of hCG is associated with lower pregnancy rate compare with group with 
ET between 7-14 mm. The pregnancy rate (PR) for those whose ET more than 14mm was 
shown to be comparable to the 7-14mm group. In contradiction to Bozdag et al, Weissman 
et al in 1999 reported a reduction in pregnancy and implantation rate when ET was more 
than 14mm on the day of hCG administration (40).  
The frequently reported cut-off of 7 mm is related to a lower chance of pregnancy, but 
occurs infrequently. Several studies suggest a thickness less than 8mm is associated with 
lower pregnancy rate. Some other authors indicate thickness of 9-14mm is associated with 
higher implantation rate compared to those with 7-8mm. A study by Geyter et al, 2000 
revealed that PR in patient with a thin endometrium was equal to those with normal 
endometrium. Based on previous studies, the lowest significant cut off value of ET was 
varied from 6-9mm. Due to the conflicting data on the best ET, the use of ET alone as a 
tool to decide on cycle cancellation, freezing of all embryos or refraining from further IVF 
treatment seems not to be justified.   
3 
 
2.2  Source population and sampling frame 
All patients subjected to receive IVF/ICSI-ET cycles. 
2.2.1 Endometrial morphology as indicator for good endometrial 
receptivity 
Endometrial morphology is described as, homogenous or presence of trilaminar layer. It is 
found that trilaminar pattern was predictive of pregnancy. However pregnancies can occur 
in absence of this pattern, albeit at a lower frequency (Leibovitz at el 1999). Failure to 
establish a homogenous hyperchogenic pattern is associated with lower pregnancy rate. 
Chen et al, 2010, conducted combined analysis of endometrial thickness and pattern in 
predicting the outcome of in vitro fertilization and embryo transfer (24). They concluded 
that the combination of ET with trilaminar pattern is associated with higher implantation 
rate. This information may be more helpful for patient counselling than the separate 
analyses. 
2.2.2 Effect of serum progesterone on endometrial receptivity 
Progesterone is a hormone of secretory phase that increases uterine receptivity by various 
mechanisms which include mast cell maturation, degranulation, production of cytokines 
and growth factors which are responsible for blastocysts implantation, successful 
conception and continuation of pregnancy. It has been debated whether the increment of 
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progesterone level in late follicular phase of controlled ovarian hyperstimulation cycle has 
a detrimental effect on the outcome of IVF (9-12). 
Rehana Rehman et al in 2014 (14) reported that high progesterone level has deleterious 
effect on endometrial secretory transformation by causing early closure of implantation 
window. They indicated its level of more than 0.784ng/ml is associated with lower 
pregnancy rate. Other studies which are in agreement that high progesterone has reversal 
effect on successful outcome gave different cut off level. Other studies reported cut off 
level of 6.0nmol/L while some have taken 3.9nmol/L as the cut of value (11-17).  
The difference in the minimum progesterone value may be contributed by different patient 
characteristic and protocol. Therefore, it is important to determine the minimum level for 
each center to improve the pregnancy rate.   
2.3 Study Justification 
The high cost and relatively low implantation and pregnancy rate in any ART treatment 
cycles have led to the need for evaluation of the predictors in these patients. Although 
many studies were previously done to evaluate the endometrial thickness during IVF/ ICSI 
cycles to predict the outcome, no conclusive cut off value of endometrial thickness could 
be obtained. In addition, the knowledge on the effect and cut off value of progesterone 
level in the serum in determining endometrial receptivity is rather new. Knowing the 
endometrial predictive factors for the success of IVF/ ICSI may not only could enhance the 
success of IVF/ ICSI cycles, the prognosis of the treatment could be discussed with the 
patients, thus helping them in making decision whether or not to proceed with the 
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treatment. Besides, having a proper understanding of the about to received treatment and its 
prognosis could reduce patient’s anxiety and stress. Anxiety and stress has been shown to 
be an independent contributory factor for failure of any fertility treatment. Because of these 
reasons,   this study, which is a part of a bigger study which looks into all the contributory 
factors for the success of IVF/ ICSI cycles, was performed. 
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3.0  OBJECTIVES 
GENERAL OBJECTIVE 
To evaluate the endometrial receptivity among patients receiving IVF/ ICSI cycles 
SPECIFIC OBJECTIVES 
1. To determine the pregnancy rate of patients going IVF/ ICSI cycles 
2. To evaluate the association between endometrial thickness and morphology with 
the outcome of IVF/ICSI cycles 
3. To evaluate the association between the level of serum progesterone on hCG 
injection day with the outcome of IVF/ICSI cycles 
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4.0  METHODOLOGY 
4.1 Study design, setting and duration 
This study was a prospective cohort study, which was done in the Hospital USM Fertility 
Unit of the Department of Obstetrics and Gynaecology, Hospital USM. It was performed 
for a period of eighteen months, from 1st February 2016 until 31st July 2017.  
4.2 Reference population 
The study includes all patients attending the Hospital USM Fertility Unit. 
4.4  Sample size calculation 
The sample size was calculated using the PS software, as in Table 1 and Table 2. 
Table 1: Sample size calculation for endometrial thickness and level of serum progesterone 
t-test Α M Power δ σ 
Sample 
size 
Endometrial 
thickness (43) 
0.05 1 0.8 4 1.6 4 
Age (43)  0.05 1 0.8 31.8 4.8 4 
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Progesterone level 
on day of hCG 
injection (31) 
0.05 1 0.8 1.48 0.9 16 
Duration of 
stimulation (36) 
0.05 1 0.8 10.2 1.9 2 
 
Table 2: Sample size calculation for endometrial morphology 
Dichotomous Α Power Po P1 m 
Sample 
size 
Endometrial 
morphology on 
day of hCG 
injection (19) 
0.05 0.8 0.38 0.78 1 23 
A minimum of 23 patients need to be recruited to meet 80% of statistical power. 50 
patients were recruited.  
4.5  Ethics and consent 
The conduct of this study  was approved by the Human Medical Research and Ethics 
Committee of USM dated 30th June 2015. 
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4.6 Inform consent  
All patient attending the Hospital USM Fertility Unit and were subjected to IVF/ICSI cycle 
were invited to participate in this study. 
The counselling on the IVF/ ICSI procedure was conducted by the Fertility Consultant. The 
indication of the IVF/ ICSI cycle, the ovulation induction protocol, the IVF/ ICSI 
procedure and its complication was explained in detail. Written consent was subsequently 
obtained from the couple. The couple was also informed that they have the right to 
withdraw from the study at any time without penalty. 
4.7 Inclusion and exclusion criteria 
4.7.1 Inclusion criteria 
All patients must fulfil the below inclusion criteria before being enrolled into the study: 
1. Agreed to receive IVF-ET/ICSI- ET in Hospital USM 
2. Patients with acceptable ovarian reserved (serum FSH <10miu/ml and/or antral 
follicles >10) 
3. Undergoing 1st cycle of fresh embryo transfer 
4.7.2 Exclusion criteria 
1. Patients with no developing embryo, or only Grade C embryos available 
2. Patients with uncontrolled diabetes mellitus 
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3. Patients with underlying psychiatric disorder 
4. Recurrent miscarriage 
5. Patients diagnosed with antiphospholipid syndrome 
6. Past or family history of inherited congenital disorders 
7. Patients with active pelvic inflammatory disease 
8. Patients with underlying TB endometritis 
4.8 Sampling method and subject recruitment  
All patients who attended the Hospital USM Fertility Unit, agreed to undergo the IVF/ 
ICSI cycle and fulfilling the inclusion and exclusion criteria were invited to participate in 
the study. The consent was taken from the patient upon her enrollment by the Fertility 
Consultant. Sampling of these patients was done according to systematic random sampling, 
by alternating sampling. 
4.9 Study method 
4.9.1 Stimulation protocol 
All patients were stimulated using the short GnRH antagonist protocol, using subcutaneous 
folitrophin beta (Puregon®) at the dose of 300iu daily, starting from the second day of 
menses of the treatment cycle. A transvaginal ultrasound was performed after 5 days of 
stimulation. Once the size of the follicles reached 13- 14mm, GnRH antagonist, garnirelix 
(Orgalutron®) at the dose 250mcg, was added. The transvaginal ultrasound scan was 
repeated every other day of stimulation, from that day onwards. 
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Once at least three follicles with the diameters of 18mm were observed, hCG (Pregnyl®) 
10,000iu, which acts as LH surrogate to trigger ovulation, was administered. If less than 
three follicles were seen, the cycle was cancelled and was considered as failed stimulation. 
This patient dropped from the study. 
The endometrial receptivity was determined by looking at the thickness and morphology of 
the endometrium, together with the level of progesterone on the day when the hCG was 
administered. For this purpose, 5cc of blood was withdrawn from the patient to determine 
the progesterone level. An ultrasound scan to determine the number of follicles stimulated, 
the thickness and morphology of the endometrium was done on the same day. The 
ultrasound scan was done by the consultant of the Hospital USM Fertility Unit. The 
endometrial thickness was determined by placing the electronic calipers on the outer walls 
of the endometrium at its widest diameter as seen in the sagittal axis of the uterine fundus. 
Endometrium pattern was graded as ‘trilaminar’, where triple lines, where the endometrium 
was hypoechoic with well- defined outer wall and a central echogenic line, was seen. The 
terminology of ‘homogenous endometrium’ was used when the endometrium was 
homogenously echodense with no visualization of central echogenic line as describe 
earlier. Endometrial evaluation was a routine part of monitoring at any stimulation cycles. 
4.9.2 Oocyte retrieval 
This procedure was performed under general anaesthesia. The transvaginal oocyte retrieval 
was performed by the consultant of the Fertility Unit, 36 hours after the administration of 
hCG. The presence of oocytes was obtained by one embryologist. Three times of follicular 
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flushing was done when no oocytes obtained at the first attempt. The number and quality of 
oocyte retrieved from each ovary was determined.  
4.9.3 Embryo culture 
All oocytes which were obtained were fertilised either by IVF or ICSI, 17 hours after the 
retrieval. The embryos were cultured in Vitrolife media. The presence of pronuclear 
cleavage was determined 24 hours later. The development of the embryo was monitored 
and graded on daily basis, with Grade A was considered as good quality embryo and Grade 
B and C were taken as poor quality embryo. The Grade A and B embryos were transferred 
at the blastocyst stage, i.e. on the 5th day of development, whilst Grade C embryo was not 
transferred as it might not be compatible to life. 
4.9.4 Embryo transfer 
The embryo was transferred transcervically into the uterus, under ultrasound guided. In 
accordance to the Malaysian government regulation of ART, not more than 2 embryos 
were transferred at a time. The good quality embryo has the best chance for implantation 
compared to the poor quality embryo. Only Grade A and Grade B embryo, to a maximum 
of two embryos, was transferred in this study. The remaining available embryos were 
cryopreserved for future usage.  
The luteal phase was supported with vaginal gel 90mg micronized progesterone (Crinone 
8%), which was administered on daily basis.  
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4.9.5 Determination of pregnancy 
Three weeks after the fresh embryo transfer, 3cc of blood  was taken to determine the level 
of beta hCG. Beta hCG of more than 0.2iu/L was taken as successful IVF cycle 
(biochemical pregnancy). An ultrasound scan of the uterus was performed two weeks later 
to determine the presence of gestational sac, which taken as successful clinical pregnancy. 
4.10 Statistical analysis 
The complete clinical research forms (CRFs) were checked and compiled. The information 
obtained in the CRFs was transferred to the computer data base file. The data was analyzed 
using statistical package SPSS version 23.0. All the variables were read and frequency runs 
were performed on them to check for errors, including coding error and missing values.  
The Chi-square test and Fisher’s exact test were used to analyze nominal variables in the 
form of frequency tables (endometrial morphology). Independent T test were used to 
analyze the numerical data, such as the endometrial thickness. Logistic regression analysis 
was performed to discriminate the independent data that would predict pregnancy rate. A p 
value of <0.05 was considered as statistically significant.  
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4.11 Definition of operational term 
 Endometrial thickness- the maximal distance between echogenic interfaces of the 
myometrium and the endometrium and measured in the mid sagittal plane by two 
dimensional trans vaginal ultrasound 
 In vitro fertilization (IVF)- insemination in vitro. The capacitated sperm were 
placed into culture media containing oocyte within 4-6 hours post retrieval. 
 Intracytoplasmic sperm injection (ICSI)- one single spermatozoa was injected 
directly into the cytoplasm of an oocyte by micropuncture of zona pellucida under 
high quality inverted operating microscope. 
 Oocyte retrieval- a procedure done to retrieve oocyte via vaginal needle under 
ultrasound guidance 36 hours after hCG injection 
 Embryo transfer- fertilized ova at blastocyst stage were place into uterine cavity 
close to fundus , on the fifth day of fertilization, through a fine flexible soft catheter 
transcervically 
 High quality embryo- grade A embryo- with even blastomeres and fragmentation 
 Grade B embryo-even blastomere and less than 20% fragmentation 
 Fresh embryo- embryo from fertilized ova at blastocyst stage 
 hCG- human chorionic gonadotrophin 
 Ovolution induction- process where drugs or hormone given to enhance the number 
and development of follicles  
 Aspermia- failure of emission of semen (no ejaculate)  
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4.12 Study flow chart 
The flow chart of the study is as shown in Figure 1. 
 
Figure 1: Study Flow Chart 
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ABSTRACT 
OBJECTIVE: To evaluate the association of endometrial receptivity by means of 
endometrial thickness, endometrial morphology and the level of serum progesterone with 
the outcome of in vitro fertilization/ intracytoplasmic sperm injection (IVF/ICSI) cycles.    
STUDY METHOD: This prospective study was performed over a period of 18 months in 
Hospital USM Fertility Unit. A total of 50 patients going to receive IVF/ICSI cycles 
participated in the study. 50 subjects had undergone controlled ovarian hyperstimulation 
protocol until mature follicles were observed. On the day when the patient is to receive 
hCG injection, the endometrial thickness, endometrial morphology and the level of serum 
progesterone were determined. Oocyte retrieval was done followed by in-vitro fertilization 
or intracytoplasmic sperm injection. The developing embryos were transferred into the 
uterus at blastocyst stage. Serum beta hCG was measured 14 days after embryo transfer. 
The association between endometrial thickness, endometrial morphology and level of 
serum progesterone with pregnancy was analysed.  
RESULT: Pregnancy was achieved in 10 out of 50 patients (20.0%). The mean 
endometrial thickness for the pregnant group was 9.86 ±1.68 mm, whilst  9.77+ 2.53mm in 
the non-pregnant group. 7 out of 10 pregnant patients had trilaminar endometrium. The 
mean progesterone level during the hCG day was 3.717 ± 1.071 nmol/L for the pregnant 
group and 1.408 ± 4.691 nmol/L for the non-pregnant group. All differences were not 
statistically significant. 
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CONCLUSION: Endometrial thickness, endometrial morphology and the level of serum 
progesterone on the hCG day was not significantly associated with the outcome of IVF/ 
ICSI cycles. However, this finding was guarded by the small sample size.  
 
Keywords: Endometrial receptivity, endometrial thickness, progesterone level, IVF/ ICSI 
cycles 
 
 
  
20 
 
INTRODUCTION 
The advancement of assisted reproductive techniques has led to the improvement of 
pregnancy rates with in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) 
cycles. However, despite the advance techniques used, there were lots of failed cycles 
which have led to disappointment and more stressful condition among the couples who 
sought the treatment. The stressful condition has virtuously caused an increasing rate of 
failed cycle. For decades, researchers have tried to look at the factors which may contribute 
to the failure of IVF/ ICSI cycles. Endometrial receptivity has been shown to be one of the 
factors. 
Endometrial thickens during the proliferative phase of the menstrual cycle in response to 
the oestrogen secretion by the maturing follicles. The thickened endometrium provides a 
site for embryo implantation during the first few weeks until placenta develops. Although 
there is little doubt that the physiological thickness of the endometrium is critical in the 
implantation of a successful pregnancy, there is still a controversy on the variation of 
thickness contributing to the success of IVF/ ICSI cycles.  
Several studies have suggested a correlation between greater endometrial thickness (ET) 
for pregnant versus non-pregnant of IVF/ ICSI cycles (1-7). Some studies have reported 
non-successful pregnancies with ET below 6-9mm, even though the number of transfers to 
patients below this threshold were small (5-10). In contrast, many studies reported that 
there was no correlation between ET with pregnancy rates (9-10).  
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The current study was designed to determine the correlation between endometrial 
receptivity, which include ET and endometrial morphology and level of progesterone 
during hCG injection day with pregnancy in IVF/ ICSI cycles. Should it be significantly 
correlated, to identify the thickness required for successful implantation. 
METHODOLOGY 
This study was conducted over a period of 18 months, from 1st February 2016 until 31st 
July 2017, in the Hospital USM Fertility Unit. Approval to conduct this study was obtained 
from the Human Medical Research and Ethics Committee of USM. All patients who were 
subjected for IVF/ ICSI cycle were recruited using the systematic random sampling 
method. Patients with medical illnesses such as uncontrolled diabetes mellitus, 
antiphospholipid disorders, active pelvic inflammatory disease, tuberculosis, psychiatric 
illness and recurrent miscarriages were excluded. 
Patients were stimulated using the short antagonist protocol. Subcutaneous follitrophin beta 
(Puregon®) at 300iu was administered on daily basis starting from the second day of 
menstrual cycle. Every other day of transvaginal scan were performed starting from day 
seventh of the cycle to determine the number and size of growing follicles. When at least 
three dominant follicles reached 13 to 14mm in diameter, additional 250mg of GnRH 
antagonist (Orgalutron®) injections were added, to prevent from premature LH surge 
which may cause premature ovulation, until the growing follicles mature at sizes of 16- 
18mm in diameter. At this stage, the number of mature follicles, endometrial thickness and 
morphology, as well as the level of serum progesterone were determined, and10000iu of 
hCG injection was administered at 2200hour on the same day. 
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Ultrasound guided oocyte retrieval was performed 36 hours later with the patient put under 
general anaesthesia. The number of the oocyte obtained was documented. The oocyte was 
then inseminated either using the IVF or ICSI as appropriate, using the Vitrolife® culture 
media. The success of fertilization was determined 17 hours later by looking at the 
presence of pronuclear body. Subsequently the embryos were cultured until they reached 
blastocyst stage. The blastocyst –stage embryos were transferred into the uterus five days 
after fertilization, under ultrasound guidance. Prior to the transfer, the quality of the 
embryos were determined. Only two embryos were transferred at a time. The remaining 
embryos were frozen in liquid nitrogen. Progesterone supplementation was given to all 
patients after the transfer. 
The serum level of beta hCG was determined three weeks after the transfer. Patients with 
serum beta hCG more than 2miu/L was labeled as having biochemical pregnancy. Clinical 
pregnancy was defined by visualization of gestational sac on ultrasound 3 weeks after 
embryo transfer. 
The relationship between patients’ age, stimulation length, embryo- quality score, 
endometrial thickness, morphology and serum progesterone on hCG injection day with 
success of implantation was determined by t-test. The primary infertility diagnosis was 
compared by chi-square analysis. Receiver operating characteristic (ROC) analysis was use 
to evaluate the discriminatory ability of endometrial thickness. 
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RESULTS 
Out of 58 patients initially enrolled, only 50 patients completed the cycle until embryo 
transfer.  2 patients whose age 39 and 42 years had empty oocyte syndrome, 4 patients 
developed ovarian hyperstimulation syndrome for which the embryo transfer were 
deferred, and 1 patient had all Grade C embryos and another patient had arrested embryo. 
The flow chart of the patients’ recruitment is as shown in Figure 3. 
Patients ages ranged from 26 – 43 years (mean age of 34.74 ± 4.34 years). 41 patients 
(82.0%) were having primary infertility while the remaining 9 patients (18.0%) were 
secondary infertility. The mean duration of subfertility was 7.70 ± 2.95 years. Endometrial 
thickness on day of hCG administration ranged from 6.1 to 14mm (mean endometrial 
thickness 9.6 ± 2.36 mm). The endometrium during the hCG day was noted to be trilaminar 
in 25 patients (50.0%) and another half was having homogenous morphology of 
endometrium. The mean level of serum progesterone on hCG day was 6.20 ± 11.49 
nmol/L.  
Out of 50 patients who had completed the study, pregnancy was achieved in ten patients 
(20.0%). Among them, two patients were delivered at term, one patient had preterm 
prelabour rupture of membranes at 30 weeks, one patient with ongoing pregnancy while the 
rest aborted during the first trimester. The other 40 patients (80.0%) failed to achieve 
pregnancy after the IVF/ ICSI procedure.  
Table 3 describes the patients’ and cycle characteristic between the pregnant and non-
pregnant group. There was no difference in the age of the patients in either group. Patients 
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achieving pregnancy seems to have longer duration of subfertility. Female factor remains 
the leading cause of subfertility in the pregnant group (60.0%) whilst combination of 
female and male factors is the leading cause for the non-pregnant group (35.0%). Patients 
who managed to achieve pregnancy have shorter stimulation days (10.44 ± 0.88 days) as 
compared to the non-pregnant group (11.59 ± 1.69 days).  
When looking at the ET, most patients have endometrium of more than 8mm thick on the 
hCG day, regardless of the outcome of pregnancy (9.86 ± 1.68mm and 9.77 ± 2.53mm for 
pregnant and non-pregnant group respectively). However, patients achieving pregnancy 
have thicker mean ET. None of the pregnant patients have ET of less than 7mm or more 
than 14mm.  
Most of the pregnant patients have trilaminar endometrium on the hCG day (n=7, 70.0%). 
55.0% of the non-pregnant group were noted to have homogenous pattern while only 
45.0% of them have trilaminar pattern. 
The mean serum progesterone on the hCG day in the pregnant group was 3.717 ± 1.071 
nmol/L and 1.408 ± 4.691 nmol/L for the non-pregnant group. None of the pregnant 
patients has serum progesterone more than 6.0 nmol/L. The lowest serum progesterone in 
the pregnant group was 1.29 nmol/L and the highest was 5.39 nmol/L.  
Due to the imbalance number between the pregnant and non-pregnant group, significant 
comparison could not be made. However, when the number is balanced and compared, 
none of the variables to test for endometrial receptivity is significant. 
 
